<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    WINDCHIME HEALTH, INC.

    WINDCHIME HEALTH, INC.

    Windchime Health is here to help both patients and dentists. Their SaaS solution a...

    Windchime Health is here to help both patients ...

    Fundraising Status:    SD
    Filing Type:    CF
    DLH Holdings Corp.

    DLH Holdings Corp.

    DLH (NASDAQ:DLHC) serves federal government clients throughout the United States a...

    DLH (NASDAQ:DLHC) serves federal government cli...

    Filing Type:    PU
    I-PASS Patient Safety Institute, Inc.

    I-PASS Patient Safety Institute, Inc.

    We help save lives by improving verbal and written communications that occur betwe...

    We help save lives by improving verbal and writ...

    Amount Raised:    $149,055.00
    Fundraising Status:    EC
    Filing Type:    CF
    Pacira BioSciences, Inc.

    Pacira BioSciences, Inc.

    Pacira BioSciences, Inc. is a specialty pharmaceutical company focused on the deve...

    Pacira BioSciences, Inc. is a specialty pharmac...

    Filing Type:    PU
    Titan Pharmaceuticals, Inc.

    Titan Pharmaceuticals, Inc.

    Titan is a specialty pharmaceuticals company that develops therapeutics for select...

    Titan is a specialty pharmaceuticals company th...

    Filing Type:    PU
    Alimera Sciences, Inc.

    Alimera Sciences, Inc.

    Alimera Sciences (NASDAQ: ALIM), founded in June 2003, is a pharmaceutical company...

    Alimera Sciences (NASDAQ: ALIM), founded in Jun...

    Filing Type:    PU
    ViewRay, Inc.

    ViewRay, Inc.

    ViewRayÂŽ Inc., (NASDAQ:VRAY), designs, manufactures and markets MRIdianÂŽ the wor...

    ViewRayÂŽ Inc., (NASDAQ:VRAY), designs, manufac...

    Filing Type:    PU
    Takeda Pharmaceutical Co., Ltd.

    Takeda Pharmaceutical Co., Ltd.

    Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-base...

    Takeda Pharmaceutical Company Limited (TSE:4502...

    Filing Type:    PU
    HOOKIPA Pharma Inc.

    HOOKIPA Pharma Inc.

    HOOKIPA Pharma Inc. is a clinical stage biopharmaceutical company developing a new...

    HOOKIPA Pharma Inc. is a clinical stage biophar...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.